-+ 0.00%
-+ 0.00%
-+ 0.00%

BridgeBio Oncology Q4 EPS $(0.49) Beats $(0.56) Estimate

Benzinga·03/05/2026 21:10:44
Listen to the news
BridgeBio Oncology (NASDAQ:BBOT) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.56) by 13.12 percent.